KE3711A - 2-phenoxyalkyl-1,2,4-triazol-3-one antidepressants - Google Patents

2-phenoxyalkyl-1,2,4-triazol-3-one antidepressants

Info

Publication number
KE3711A
KE3711A KE3711A KE371187A KE3711A KE 3711 A KE3711 A KE 3711A KE 3711 A KE3711 A KE 3711A KE 371187 A KE371187 A KE 371187A KE 3711 A KE3711 A KE 3711A
Authority
KE
Kenya
Prior art keywords
phenoxyalkyl
antidepressants
triazol
Prior art date
Application number
KE3711A
Other languages
English (en)
Inventor
L Temple David
G Lobeck Walter
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22922879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KE3711(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of KE3711A publication Critical patent/KE3711A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KE3711A 1981-03-16 1987-03-31 2-phenoxyalkyl-1,2,4-triazol-3-one antidepressants KE3711A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/244,464 US4338317A (en) 1981-03-16 1981-03-16 Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Publications (1)

Publication Number Publication Date
KE3711A true KE3711A (en) 1987-04-30

Family

ID=22922879

Family Applications (1)

Application Number Title Priority Date Filing Date
KE3711A KE3711A (en) 1981-03-16 1987-03-31 2-phenoxyalkyl-1,2,4-triazol-3-one antidepressants

Country Status (26)

Country Link
US (1) US4338317A (fr)
JP (1) JPS57159774A (fr)
KR (1) KR880001374B1 (fr)
AT (1) AT384022B (fr)
BE (1) BE892503A (fr)
CA (1) CA1198436A (fr)
CH (1) CH649539A5 (fr)
CY (1) CY1373A (fr)
DE (1) DE3209557A1 (fr)
DK (1) DK158728C (fr)
ES (1) ES510449A0 (fr)
FI (1) FI73670C (fr)
FR (1) FR2501690B1 (fr)
GB (1) GB2096137B (fr)
GR (1) GR76076B (fr)
HK (1) HK4788A (fr)
IE (1) IE52788B1 (fr)
IT (1) IT1148137B (fr)
KE (1) KE3711A (fr)
LU (1) LU84011A1 (fr)
MX (1) MX9203176A (fr)
NL (2) NL190757C (fr)
SE (1) SE447256B (fr)
SG (1) SG30287G (fr)
YU (1) YU43256B (fr)
ZA (1) ZA821359B (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
AT388555B (de) * 1983-06-29 1989-07-25 Bristol Myers Co Verfahren zur herstellung von neuen 1,2,4-triazol-3-on-derivaten
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1248531A (fr) * 1984-04-17 1989-01-10 Jeffrey C. Watkins Derives de substitution en 4 d'acides piperazine-2- carboxyliques
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2160423A1 (fr) * 1994-11-02 1996-05-03 Hemant N. Joshi Sels de nefazodone a taux de dissolution ameliores
EP0769297A1 (fr) 1995-10-17 1997-04-23 Bristol-Myers Squibb Company Utilisation de néfazodone pour la fabrication d'un médicament pour le traitement d'attaques de panique
CA2182241C (fr) * 1996-07-29 2002-09-17 Bo Lei Methodes pour la preparation de nefazodone
AU2452397A (en) * 1996-07-31 1998-02-20 Bristol-Myers Squibb Company Nefazodone: use in migraine prophylaxis
US5852020A (en) * 1996-11-22 1998-12-22 Bristol-Myers Squibb Company Nefazodone: use in treating post traumatic stress disorder
US5735873A (en) * 1996-12-19 1998-04-07 Maclean; David S. Surgical tool handle
US5917050A (en) * 1998-02-11 1999-06-29 Bayer Corporation Process for preparing alkoxytriazolinones
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
US6706282B1 (en) 1998-11-02 2004-03-16 Evangeline Cruz Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
AU4215300A (en) 1999-04-09 2000-11-14 Sepracor, Inc. R-hydroxynefazodone
WO2000061129A2 (fr) * 1999-04-09 2000-10-19 Sepracor Inc. S-hydroxynefazodone
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
CA2356450C (fr) 2001-09-10 2003-11-25 Brantford Chemicals Inc. Synthese amelioree de chlorhydrate de nefazodone
ATE460933T1 (de) * 2002-05-24 2010-04-15 Carl-Fr Coester Pharmazeutische wirkstoffkombination sowie deren verwendung
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
US6987194B2 (en) * 2003-04-30 2006-01-17 Fmc Corporation Insecticidal (dihalopropenyl) phenylalkyl substituted dihydrobenzofuran and dihydrobenzopyran derivatives
ES2347152T3 (es) * 2003-11-26 2010-10-26 Pfizer Products Inc. Derivados de aminopirazol como inhibidores de gsk-3.
WO2005102366A2 (fr) * 2004-04-19 2005-11-03 Philip Maxwell Satow Combinaisons de lithium et utilisations associees
TW200612961A (en) * 2004-05-18 2006-05-01 Fmc Corp Substituted cyclic urea derivatives
CA2614289A1 (fr) * 2005-07-08 2007-01-18 Braincells, Inc. Methodes destinees a identifier des agents et des conditions modulant la neurogenese
EP1940389A2 (fr) 2005-10-21 2008-07-09 Braincells, Inc. Modulation de la neurogenese par inhibition de la pde
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2010502722A (ja) 2006-09-08 2010-01-28 ブレインセルス，インコーポレイティド ４−アシルアミノピリジン誘導体を含む組み合わせ
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2008083204A2 (fr) * 2006-12-28 2008-07-10 Braincells, Inc. Modulation de la neurogenèse par des ligands mélatoninergiques
AU2008204800A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
CN101827828B (zh) * 2007-08-07 2013-02-27 普罗萨里克斯有限公司 作为5-羟色胺能调节剂的1,2,4-三唑衍生物
US9339500B2 (en) 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
US20110034565A1 (en) 2008-04-18 2011-02-10 University College Dublin, National University Of Ireland, Dublin Psycho-pharmaceuticals
WO2010099217A1 (fr) 2009-02-25 2010-09-02 Braincells, Inc. Modulation de neurogenèse à l'aide de combinaisons de d-cyclosérine
TWI368512B (en) * 2009-04-30 2012-07-21 Univ Kaohsiung Medical Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments
WO2012072665A1 (fr) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprenant de la pipampérone et des antagonistes/inhibiteurs de la recapture de la sérotonine
CN104402842A (zh) * 2014-11-19 2015-03-11 苏州乔纳森新材料科技有限公司 一种哌嗪类药物中间体的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione

Also Published As

Publication number Publication date
NL8201021A (nl) 1982-10-18
FR2501690A1 (fr) 1982-09-17
ATA104582A (de) 1987-02-15
SE8201631L (sv) 1982-09-17
IT8247978A0 (it) 1982-03-12
AT384022B (de) 1987-09-25
CY1373A (en) 1987-08-07
ES8305756A1 (es) 1983-04-16
LU84011A1 (fr) 1983-02-22
GB2096137B (en) 1985-01-03
DE3209557C2 (fr) 1993-07-15
ZA821359B (en) 1983-01-26
AU8117082A (en) 1982-09-23
DK158728C (da) 1990-12-03
NL970014I2 (nl) 1997-09-01
NL970014I1 (nl) 1997-06-02
AU555888B2 (en) 1986-10-16
FI73670C (fi) 1987-11-09
IE52788B1 (en) 1988-03-02
GB2096137A (en) 1982-10-13
US4338317A (en) 1982-07-06
KR880001374B1 (ko) 1988-07-29
JPH0237353B2 (fr) 1990-08-23
ES510449A0 (es) 1983-04-16
KR830009089A (ko) 1983-12-17
FR2501690B1 (fr) 1985-07-05
YU43256B (en) 1989-06-30
DE3209557A1 (de) 1982-12-09
MX9203176A (es) 1992-07-01
DK158728B (da) 1990-07-09
SE447256B (sv) 1986-11-03
FI73670B (fi) 1987-07-31
CH649539A5 (de) 1985-05-31
BE892503A (fr) 1982-09-15
IT1148137B (it) 1986-11-26
FI820856L (fi) 1982-09-17
CA1198436A (fr) 1985-12-24
NL190757C (nl) 1994-08-01
SG30287G (en) 1987-07-17
YU52582A (en) 1985-06-30
DK112582A (da) 1982-09-17
GR76076B (fr) 1984-08-03
NL190757B (nl) 1994-03-01
IE820589L (en) 1982-09-16
HK4788A (en) 1988-01-29
JPS57159774A (en) 1982-10-01

Similar Documents

Publication Publication Date Title
HK4788A (en) 2-phenoxyalkyl-1,2,4-triazol-3-one antidepressants
GB2142631B (en) 1,2,4-triazol-3-one antidepressants
GB2118556B (en) 26,26,26,27,27,27-hexafluoro-cholesterol derivatives
GB2106902B (en) 2,2-disubstituted-ethylamines
GB2109371B (en) Fungicidal 1,2,4-triazole derivatives
CS256182A2 (en) Zpusob vyroby novych 2,3,4 trinor m interfenylenprostacyklu novych derivatu
CS770482A2 (en) Zpusob vyroby 1 (3 benzyloxyfenyl) 1,1 dimethylheptanu
GB2125788B (en) 17,18-dehydro-apovincaminol
IL66673A0 (en) 3'-substituted-5'-(2-amino-4-pyridyl)-1',2',4'-triazoles
GB2102429B (en) 9-hydroxy-3-oxo-4,17(20)-pregnadiene-20-carboxaldehyde
CS914282A2 (en) Hydraulicky valec, zejmena dulni vzpera s kombinovanou funkci
PH18356A (en) Phenoxyphenyl-tetrahydro-1,3,5-thidiazin-4-ones
GB8515706D0 (en) Preparing 2,2,6,6-tetremethyl-4-oxopiperidine
IE841649L (en) 1,2,4-triazol-3-one antidepressants
EP0058885A3 (en) Herbicidal 1,2,4-triazin-5-ones
IE813047L (en) 4, 5-diaryl-ó-(polyhalomethyl)-2-thiophenemethanols
IE813046L (en) 4, 5-diaryl-ó,ó-bis-(polyhalomethyl)-2-thiophenemethanamines
GB2106513B (en) Imidazo- and pyrimido-1,3,5-thiadiazin-4-ones
GB2098605B (en) 1,3-dihydro-2h-imidazol-2-ones
IE790309L (en) 1,2,4-triazoles.
CS713382A1 (en) Napravnice nakladnich automobilu s ohyby, ohranicenymi klinovitymi vyrezy
SU1048747A1 (ru) 9,9-диметил-8,10-динитро-1,6-диазатрицикло[6,3,1,1]
CS610981A1 (en) Zpusob vyroby derivatu 1 fenyl 1,2,3,4 tetrahydronaftalenu
IE810990L (en) 1,2-oxazoles
IE812628L (en) 1,2,4-triazole derivatives